William Altman, M.B.A.

Mr. William Altman is the President & CEO of CorrInova, Inc. an innovative device-based therapies company for the treatment of congestive heart failure.  Mr. Altman is a senior healthcare executive with over 20 years experience in private equity, management consulting and C-level and Board level management of both public and private companies. Prior to CorrInova he helped build senior management teams as Senior Client Partner in the Houston office of Korn/Ferry International and prior to that served as President & CEO of Kardia Therapeutics.

Mr. Altman was a Rhodes Scholar at Oxford University, received a B.S. in Electrical Engineering from Texas A&M University and an M.B.A. from Harvard Business School.